Novavax
NVAX
#5502
Rank
HK$10.24 B
Marketcap
HK$62.86
Share price
-1.47%
Change (1 day)
34.63%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : HK$10.22 Billion

According to Novavax's latest financial reports the company's total liabilities are HK$10.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$10.14 B-40.16%
2024-12-31HK$16.95 B-13.65%
2023-12-31HK$19.63 B-13.11%
2022-12-31HK$22.60 B-1.02%
2021-12-31HK$22.83 B208.35%
2020-12-31HK$7.40 B164.88%
2019-12-31HK$2.79 B-5.03%
2018-12-31HK$2.94 B-6.79%
2017-12-31HK$3.15 B1.86%
2016-12-31HK$3.10 B328.46%
2015-12-31HK$0.72 B101.15%
2014-12-31HK$0.35 B45.49%
2013-12-31HK$0.24 B44.33%
2012-12-31HK$0.17 B73.33%
2011-12-31HK$98.84 M-19.58%
2010-12-31HK$0.12 B1.27%
2009-12-31HK$0.12 B-49.56%
2008-12-31HK$0.24 B9.33%
2007-12-31HK$0.22 B1.51%
2006-12-31HK$0.21 B-19.48%
2005-12-31HK$0.26 B-22.5%
2004-12-31HK$0.34 B-7.03%
2003-12-31HK$0.37 B-3.05%
2002-12-31HK$0.38 B24.77%
2001-12-31HK$0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
HK$504.72 B 4,837.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$951.33 B 9,206.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$512.20 B 4,910.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$476.67 B 4,563.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$17.31 B 69.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.43 B-95.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$4.03 B-60.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$9.26 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$4.96 B-51.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.88 B-32.64%๐Ÿ‡บ๐Ÿ‡ธ USA